| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 29.964 | 96.096 | 96.894 | 179.352 |
| Total Income - EUR | - | - | - | - | - | - | 29.964 | 96.096 | 96.954 | 179.352 |
| Total Expenses - EUR | - | - | - | - | - | - | 6.225 | 17.518 | 25.791 | 24.142 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 23.739 | 78.578 | 71.163 | 155.210 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 22.840 | 76.492 | 70.291 | 150.636 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - B&C Gyori Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 43.253 | 32.080 | 20.381 | 12.975 |
| Current Assets | - | - | - | - | - | - | 8.432 | 66.506 | 65.423 | 146.220 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 1.213 | 60.493 | 59.045 | 122.910 |
| Cash | - | - | - | - | - | - | 7.219 | 6.013 | 6.377 | 23.310 |
| Shareholders Funds | - | - | - | - | - | - | 22.880 | 76.541 | 70.340 | 150.785 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 28.805 | 22.045 | 15.463 | 8.410 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - B&C Gyori Medical S.r.l.